Cell analysis for hematopoietic stem/progenitor cell transplantation

被引:0
作者
Law, P
Traylor, L
Recktenwald, DJ
机构
[1] BD Biosci, San Jose, CA 95131 USA
[2] Univ Calif San Diego, Blood & Marrow Transplantat Program, La Jolla, CA USA
[3] AmCell Corp, Sunnyvale, CA USA
来源
CYTOMETRY | 1999年 / 38卷 / 02期
关键词
progenitor/stem cell subsets; cytometry; transplantation;
D O I
10.1002/(SICI)1097-0320(19990415)38:2<47::AID-CYTO1>3.0.CO;2-2
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Cytometric analysis has become an important aspect in the quality control of cells in all phases of hematopoietic cell transplantation. In the stage of donor conditioning the counting of stem and progenitor cells is important and several reliable single platform tests for CD34+ cells have become available recently. It has been shown, that the count of certain subsets of CD34 may predict best time for harvesting stem cells better than just CD34. In many cases manipulation of the cell sample after collection from the donor is necessary before the cells are adequate for transplantation. Characterization of the resulting cell preparations requires reliable quantitative analysis of a variety of cell types like the enumeration of T-cells at the level of one in ten thousand for some allogeneic transplantations. It is discussed how these clinical requirements will need a refinement of cytometric procedures to achieve adequate clinical decisions. Cytometry (Comm. Clin. Cytometry) 38: 47-52, 1999. (C) 1999 Wiley-Liss, Inc.
引用
收藏
页码:47 / 52
页数:6
相关论文
共 50 条
[21]   Hematopoietic Stem Cell Transplantation for Severe Combined Immunodeficiency [J].
Hoenig, M. ;
Schulz, A. ;
Friedrich, W. .
KLINISCHE PADIATRIE, 2011, 223 (06) :320-325
[22]   Hematopoietic stem cell transplantation activity in Europe 1999 [J].
Gratwohl, A ;
Passweg, J ;
Baldomero, H ;
Urbano-Ispizua, A .
BONE MARROW TRANSPLANTATION, 2001, 27 (09) :899-916
[23]   Hematopoietic stem cell transplantation in the treatment of autoimmune diseases [J].
Kozák, T .
WIENER KLINISCHE WOCHENSCHRIFT, 2002, 114 (1-2) :7-13
[24]   Hematopoietic stem cell transplantation: clinical use and perspectives [J].
Barriga, Francisco ;
Ramirez, Pablo ;
Wietstruck, Angelica ;
Rojas, Nicolas .
BIOLOGICAL RESEARCH, 2012, 45 (03) :307-316
[25]   Secondary malignancies after hematopoietic stem cell transplantation [J].
Ghelani, D ;
Saliba, R ;
de Lima, M .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2005, 56 (01) :115-126
[26]   Risk Analysis of Falls in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation [J].
Ueki, Satoko ;
Ikegame, Kazuhiro ;
Kozawa, Mariko ;
Miyamoto, Junko ;
Mori, Reiko ;
Ogawa, Hiroyasu .
CLINICAL JOURNAL OF ONCOLOGY NURSING, 2014, 18 (04) :396-399
[27]   Autologous Hematopoietic Stem Cell Transplantation for Systemic Sclerosis [J].
Milanetti, Francesca ;
Bucha, Jurate ;
Testori, Alessandro ;
Burt, Richard K. .
CURRENT STEM CELL RESEARCH & THERAPY, 2011, 6 (01) :16-28
[28]   Lifetime probabilities of hematopoietic stem cell transplantation in the US [J].
Nietfeld, J. J. ;
Pasquini, Marcelo C. ;
Logan, Brent R. ;
Vertei, Frances ;
Horowitz, Mary M. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (03) :316-322
[29]   Heterogeneity in hematopoietic stem cell populations: implications for transplantation [J].
Miller, Paul H. ;
Knapp, David J. H. F. ;
Eaves, Connie J. .
CURRENT OPINION IN HEMATOLOGY, 2013, 20 (04) :257-264
[30]   Impact of Hematopoietic Stem Cell Transplantation on Dental Development [J].
Ruyssinck, Laure ;
Toulouse, Kaat ;
de Braem, Victoria Bordon Cueto ;
Cauwels, Rita ;
Dhooge, Catharina .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (01) :107-113